Pascal Soriot
Executive Director and Chief Executive Officer
@astrazeneca.com+46085XXXXXXX
Per Alfredsson
Senior Vice President for Global Biologics Operations and CEO of AstraZeneca AB
@astrazeneca.com+46 (0)8-5XXXXXXX
David Brocklehurst
Vice President, Global Franchise Head, DDR & Gynaecological/Genitourinary Cancers
@astrazeneca.com
Dafni Bika
Senior Vice President and Global Head of Pharmaceutical Technology and Development (PT&D), Global Operations
@astrazeneca.com
Philip Broadley
Senior independent Non-Executive Director
@astrazeneca.com
Jorge Reis-Filho
Chief AI and Data Scientist, Oncology R&D, Astrazeneca
@astrazeneca.com
Rodolphe Grepinet
SVP Corporate Development
@astrazeneca.com
Matt Hellmann
Vice President, Early Oncology Development, AstraZeneca
@astrazeneca.com
Martin Cowie
Vice President Clinical Cardiovascular and Renal Clinical Development, BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Kay Tait
Executive Director, Transactions
@astrazeneca.com
Iskra Reic
Executive Vice-President, International
@astrazeneca.com
Ryan Hicks
Head of Bioscience Cell Therapy, BioPharmaceuticals R&D
@astrazeneca.com
Leora Horn
Global Clinical Head for Lung Cancer and Lung Cancer Strategy
@astrazeneca.com
Jeff Pott
Chief Human Resources Officer, Chief Compliance Officer and General Counsel
@astrazeneca.com
Anas Younes
Senior Vice President, Global Head of Haematology (Early and Late Stage) Oncology R&D
@astrazeneca.com
Andrew Foxley
Vice President, Franchise Head, Late Oncology R&D
@astrazeneca.com
Adam Platt
VP and Head of Translational Science and Experimental Medicine, Respiratory and Immunology, AstraZeneca
@astrazeneca.com
Shin Morita
Vice President, Oncology Business Unit
@astrazeneca.com
Suzanne Cohen
Executive Director and Head of Bioscience Asthma and Skin Immunity, Respiratory and Immunology (R&I), AstraZeneca
@astrazeneca.com
Sheri McCoy
Non-Executive Director
@astrazeneca.com
Ratan Bhat
VP and Global Head of Business Development & Licensing, BioPharmaceuticals R&D
@astrazeneca.com
Kenny Hansson
Executive Director and Head of Bioscience Cardiovascular, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca
@astrazeneca.com
Michele Sample
VP, Late Stage Oncology Clinical Operations, AstraZeneca
@astrazeneca.com
Nathan Styles
Executive Director, Head of Search & Evaluation, CVRM, BioPharmaceuticals R&D
@astrazeneca.com
Nikhil Muthal
Executive Director, Head of Search & Evaluation, Respiratory & Immunology, BioPharmaceuticals R&D
@astrazeneca.com
Sharon Barr
Executive Vice-President, BioPharmaceuticals R&D
@astrazeneca.com
Ruth March
Senior-Vice President of Precision Medicine, R&D Oncology
@astrazeneca.com
Marcus Wallenberg
Non-Executive Director
@astrazeneca.com
Anne-Claire Gerbaldi
SVP GPPM, Strategic Planning, BDO and Deal Finance
@astrazeneca.com
Ken Grime
Executive Director and Head of Bioscience COPD & IPF, Respiratory & Immunology (R&I), AstraZeneca
@astrazeneca.com
Gayatri Varma PhD
Executive Director, Head of Transactions Oncology Business Development
@astrazeneca.com
Susan Galbraith
Executive Vice-President, Oncology R&D
@astrazeneca.com
Ruud Dobber
Executive Vice-President, BioPharmaceuticals Business Unit
@astrazeneca.com
Euan Ashley
Non-Executive Director
@astrazeneca.com
Sunil Verma
Senior Vice President, Global Head, Oncology Franchise, AstraZeneca
@astrazeneca.com
Birgit Conix
Non-Executive Director
@astrazeneca.com
Diana Layfield
Non-Executive Director
@astrazeneca.com
Caterina Brindicci
Senior Vice President and Global Head of R&I Late-Stage Development, BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Rene Haas
Non-Executive Director
@astrazeneca.com
Ben Challis
VP and Head of Translational Science & Experimental Medicine, Cardiovascular, Renal and Metabolism, AstraZeneca
@astrazeneca.com
Andy Barnett
Head of Investor Relations
@astrazeneca.com
Susanna Myhre
Head of Academic Partnership, BioPharmaceuticals R&D
@astrazeneca.com
Christopher Church
Head of Search & Evaluation, Technology, BioPharmaceuticals R&D
@astrazeneca.com
David Baker
Executive Director, Head of Bioscience Metabolism, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca
@astrazeneca.com
Malin Lemurell
Executive Director and Head of Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D
@astrazeneca.com
Pam Cheng
Executive Vice President, Global Operations, IT & Chief Sustainability Officer
@astrazeneca.com
Mark Cobbold
Vice President, Discovery, Oncology R&D
@astrazeneca.com
Eniola Ashafa
PET Lead/Head of Manufacturing for Coppell Supply Site, AstraZeneca
@astrazeneca.com
Mark O’Connor
Chief Scientist, Early Oncology Discovery
@astrazeneca.com
Polly Brown
VP, Head of Business Development, Oncology R&D
@astrazeneca.com
Jim Weatherall
Chief Data Scientist, BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Lutz Jermutus
Head of Projects
@astrazeneca.com
Mina Makar
Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals Business Unit
@astrazeneca.com
Shawn Davis
Head of Drug Delivery, BioPharmaceuticals Development, R&D
@astrazeneca.com
Judy Campagnari
Executive Director, Head of Alliance and Integration Team (AIT)
@astrazeneca.com
Puja Sapra
Senior Vice President, Biologics Engineering & Oncology Targeted Discovery
@astrazeneca.com
Ian Kirk
VP, Business Development Sweden
@astrazeneca.com
Gemma Satterthwaite
Global Product Leader, Oncology Business Unit
@astrazeneca.com
David Fredrickson
Executive Vice-President, Oncology Business Unit
@astrazeneca.com
Nazneen Rahman
Non-Executive Director
@astrazeneca.com
Tonya Villafana
Vice President, Global Franchise Head, Infection
@astrazeneca.com
David Vallo
Head of Alliance Management, BioPharmaceuticals R&D
@astrazeneca.com
Christer Gruvris
Executive Director of Investor Relations
@astrazeneca.com
Teresa Klinowska
Global Product Leader, Oncology R&D
@astrazeneca.com
Regina Fritsche-Danielson
Senior Vice President and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
@astrazeneca.com
Anna Manz
Non-Executive Director
@astrazeneca.com
Mikhail Kosiborod
Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Tony Mok
Non-Executive Director
@astrazeneca.com
Victoria Parker
Executive Group Director, Metabolism, Early Clinical Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Sofia Tapani
Head of Early Respiratory & Immunology Statistics, Executive Director Statistics, AstraZeneca
@astrazeneca.com
Maurizio Scaltriti
Vice President, Translational Medicine, Early Oncology
@astrazeneca.com
Tom Keith-Roach
President, AstraZeneca UK
@astrazeneca.com
Lisa Hickey
Vice President, US Business Unit Lead Neurology
@astrazeneca.com
Karen Knudsen
Non-Executive Director
@astrazeneca.com
Femi D-Etti
Vice President & General Manager, Mount Vernon Supply, AstraZeneca
@astrazeneca.com
Caroline Austin
VP, UK and PMG Business Development
@astrazeneca.com
Joris Silon
US Country President, BioPharmaceuticals Business Unit
@astrazeneca.com
Aradhana Sarin
Executive Director and Chief Financial Officer
@astrazeneca.com
Marc Dunoyer
Chief Executive Officer, Alexion and Chief Strategy Officer, AstraZeneca
@astrazeneca.com
Bob T. Li
Global Head of Medical Affairs, Oncology, AstraZeneca
Mark T. Esser
Vice President and Head of Microbial Sciences, BioPharmaceuticals R&D
Rasmus Jansson-Löfmark
Executive Director and Head of DMPK, Early CVRM, AstraZeneca
Elisabeth Björk
SVP, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D
Ingrid A. Mayer
Global Clinical Head for Breast Cancer and Breast Cancer Strategy
Slavé Petrovski
VP, Centre for Genomics Research, BioPharmaceuticals R&D
Christopher J. Rhodes
Chief Scientist, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, and Chair of AstraZeneca’s postdoc programme
Michel Demaré
Non-Executive Chair of the Board
Ti Hwei How
Vice President, International Oncology
Elizabeth Walton
Director of Investor Relations
@astrazeneca.com
Isabel Gibson
Director of Investor Relations
@astrazeneca.com
Peter Schell
Senior Director, Business Development PT&D
@astrazeneca.com
Tatiana Scetinina
Director, Data Science, AstraZeneca
@astrazeneca.com
Anna Sundgren
Global Development Leader, Lokelma & Bydureon
@astrazeneca.com
Louise Pearson
Director of Investor Relations
@astrazeneca.com
Tatiana Kubasova
Business Development Director, Russia & Eurasia
@astrazeneca.com
Paul Leon, PhD
Senior Director, Business Development, Search & Evaluation, and Partnering
@astrazeneca.com
Richard Yuan
Associate Director, Corporate Development
@astrazeneca.com
Francesco Dazzi
Medical Lead Cell Therapies, BioPharmaceuticals R&D, AstraZeneca
@astrazeneca.com
Lauren Swales
Director of Investor Relations
@astrazeneca.com
Philip Sparks
Director of Investor Relations
@astrazeneca.com
Bing Chen
Vice President, International Business Development and Venture Fund
@astrazeneca.com
Aida Bendt
Head of Alliance Management
@astrazeneca.com
Brigitte de Lima
Senior Director, Corporate Development
@astrazeneca.com
Varun Malhotra
Director, Corporate Development
@astrazeneca.com
Andrew Christmas
Director of Investor Relations
@astrazeneca.com
Nicolas Jose Guzman
Director Physician, Nephrology Clinical Research
Gerardo Teja Rivera
Tower Lead for Global Supply Chain & Strategy and External Supply Manufacturing, Guadalajara GITC, AstraZeneca
982330378Active
AstraZeneca AB